K-V Pharmaceutical Co

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
K-V Pharmaceutical Co
CIK #0001236271, 0000057055
EDGAR Form CIK 2011 - 2025
10-K [0000057055]
10-Q [0000057055]
3 [0000057055]
4 [0000057055]
8-K [0000057055]
D [0000057055]
SC 13D [0000057055]
SC 13G [0000057055]
SC 13D [0001236271]
SC 13G [0001236271]
Form 13D/13G Filer Form 13D/13G Subject Filed
Silver Point Capital LP K-V Pharmaceutical Co [2013-09-26]
Glenview Capital Management LLC KV Pharmaceutical Co /DE/ [2013-08-05]
Capital Ventures International KV Pharmaceutical Co /DE/ [2013-08-01]
Greywolf Capital Management LP KV Pharmaceutical Co /DE/ [2013-07-24]
Greywolf Capital Management LP K V Pharmaceutical Co [2013-07-23]
Kingdon Capital Management LLC KV Pharmaceutical Co /DE/ [2013-07-16]
Deutsche Bank AG KV Pharmaceutical Co /DE/ [2013-07-12]
Greywolf Capital Management LP K V Pharmaceutical Co [2012-12-14]
Kingdon Capital Management LLC KV Pharmaceutical Co /DE/ [2012-01-26]
Form 3/4/5 Subject 2011 - 2025
Christmas Patrick J.
K-V Pharmaceutical Co
McHugh Thomas S
McInnis Joe
Nielson Steven
Goldfarb James M.
Norden Gregory
Vergis Janet S.
Joseph Mahady M
Divis Gregory J
Silver Point Capital L.P.
Mule Edward A
O'Shea Robert J
Haron Eric
Siegel Jonathan B.
Baldini Robert E
Stancic Ana
Bentley Gregory Smith
Hermelin David S
Dow Mark A.
Sidransky David
Lehrer Joseph D
Robbins Larry
Glenview Capital Management LLC
Parkside Financial Bank & Trust
Terms | Privacy | Guide
tony@aum13f.com